Jamie Heywood

Jamie Heywood is the CEO and Founder of Alden Scientific, a position he has held since August 2020. He is based in Newton, Massachusetts, and has a strong background in the healthcare and biotechnology sectors.

Professional Background

Heywood has an extensive career in various leadership roles, including:

• Board Member at the International Consortium for Health Outcomes Measurement (ICHOM) since August 2019.
• Advisory Council Member for the Center for the Neuroscience of Psychedelics at Harvard Medical School and Massachusetts General Hospital since October 2020.
• Co-Founder and Board Member of AoBiome since August 2012.
• Founder and former CEO of PatientsLikeMe, where he worked from 2005 until November 2019.

He has also served in various capacities at organizations such as the ALS Therapy Development Institute and iCarbonX, showcasing his commitment to advancing healthcare outcomes and patient-centric innovations. Heywood's educational background includes a degree from the Massachusetts Institute of Technology (MIT) .1

Contributions and Recognition

Jamie Heywood is recognized for his innovative approaches in the healthcare industry, particularly in leveraging technology to improve patient outcomes. He has been involved in initiatives that emphasize the importance of data sharing and community engagement in healthcare, which has led to significant advancements in understanding and treating diseases like ALS. His work has earned him accolades, including features in Wired Magazine's "The Smart List" for his groundbreaking ideas .1